Discover why companies struggle to switch to open-source AI models like GLM 5.2 despite significant cost savings and performance advantages over Claude.
IND authorization paves the way for initiation of GT-02287 Phase 2 clinical development in the U.S., expected during 3Q26 ...
AI accountability is becoming a boardroom question. Directors need reviewable evidence on AI uses, owners, data exposure, ...
Discover how automation, AI, and organoid technologies are improving drug discovery through scalable workflows.
In Vancouver, demonstrators marched from the Vancouver Art Gallery to City Hall against two proposed TELUS-linked AI data ...
Aging infrastructure is hampering the country’s ability to maintain a technically advanced warfighting capability, says the Defense Research Enterprise Review.
The hyperscalers are under pressure and the message from the market is clear: show us the money or cut back your investments.
Creating new housing supply involves a lot of stakeholders who sometimes have little to no housing experience yet have a ...
Embedded AI is now one of the most powerful levers available to boards seeking profitability, productivity and long-term competitivenes, reveals Sergio Maccotta, senior vice president and general ...
Entries will be assessed on criteria including AI integration, spatial intelligence, feasibility, sustainability, inclusivity, human-centred design and the ability to translate data into practical des ...
Objective Hydroxychloroquine (HCQ) is a cornerstone therapy for SLE, reducing flares, organ damage and mortality. However, ...
As 2026 approaches, growing companies face a critical junction where traditional business practices intersect with rapidly evolving ...